Therapy News and Research

RSS

CRF to sponsor Women's Heart Health Summit

The Cardiovascular Research Foundation (CRF) will sponsor the Women's Heart Health Summit: "In Pursuit of Excellence: Improving Cardiovascular Outcomes in Women." The goal of the meeting is to examine current prevention, treatment, and key research issues to collectively identify opportunities and recommendations that will lead to improved cardiovascular outcomes in women.

22 Nov 2011

Gene-therapy trial to restore hearing in deaf mice

Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.

22 Nov 2011

Scientists search for main culprit behind Sj-gren's syndrome

Researchers want to find the main culprit behind the dry, irritated eyes, mouth, throat, skin, nose and more afflicting 1-3 percent of the population.

22 Nov 2011

Researchers manipulate life span of yeast by mutating chemical residues

Collaborations between Johns Hopkins and National Taiwan University researchers have successfully manipulated the life span of common, single-celled yeast organisms by figuring out how to remove and restore protein functions related to yeast aging.

22 Nov 2011

FDA clears TSC's OncoTrac medical imaging software

Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.

22 Nov 2011

Scientists design math model that could guide future prostate cancer treatments

Scientists have designed a first draft of a mathematical model that someday could guide treatment decisions for advanced prostate cancer, in part by helping doctors predict how individual patients will respond to therapy based on the biology of their tumors.

22 Nov 2011

Study reveals PEA-15 protein can enhance cancer cell proliferation

A new study from the University of Hawaii Cancer Center reveals that PEA-15, a protein previously shown to slow ovarian tumor growth and metastasis, can alternatively enhance tumor formation in kidney cells carrying a mutation in a cancer-promoting gene called H-Ras.

22 Nov 2011

Despite market constraints, the drug market for key hospital-treated infections will increase: Report

Decision Resources finds that the drug market for key hospital-treated infections that are of high interest to drug developers—most notably nosocomial pneumonia, bloodstream infections, skin and skin structure/surgical site infections and urinary tract infections—will increase from $3.3 billion in 2010 to just over $4 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

21 Nov 2011

Covidien to acquire BÂRRX Medical

Covidien, a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire BÂRRX Medical, Inc. BÂRRX is the leader in treatment of Barrett's esophagus syndrome using bipolar radiofrequency (RF) ablation devices.

21 Nov 2011

2011 National Report Card on Lung Cancer notes significant change in grade for early detection

Today, Lung Cancer Alliance (LCA), the leading national support and advocacy voice for those at risk for or living with lung cancer, issued its annual 2011 National Report Card on Lung Cancer, an overall assessment of the nation's response to the continuing high mortality of lung cancer, the leading cause of cancer death.

21 Nov 2011

PLoS ONE publishes study on darinaparsin, a multivalent chemotherapeutic

ZIOPHARM Oncology, Inc. announced today the publication of a darinaparsin (Zinapar or ZIO-101) study in the PLoS ONE, an international, peer-reviewed, open-access, online publication of the Public Library of Science.

21 Nov 2011

Multi-center cabozantinib trial for hormone receptor-positive breast cancer with bone metastases initiated

Exelixis, Inc. today announced the initiation of an investigator-sponsored trial of cabozantinib in women with hormone receptor-positive breast cancer with bone metastases.

21 Nov 2011

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).

21 Nov 2011

FDA grants HDE marketing approval for BSD-2000 Hyperthermia System to treat cervical cancer

BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has obtained Humanitarian Device Exemption (HDE) marketing approval for the BSD-2000 Hyperthermia System (BSD-2000) from the U.S. Food and Drug Administration.

21 Nov 2011

OTS to market and disribute RaySearch's RayStation in South Korea

...

21 Nov 2011

Convergence commences CNV2197944 multiple ascending dose Phase I study for chronic pain

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.

21 Nov 2011

PEPFAR Scientific Advisory Board report offers six recommended research priorities

This post in the Center for Global Health Policy's "Science Speaks" blog examines a report by the PEPFAR Scientific Advisory Board (SAB) that offers six recommended treatment and prevention research priorities to U.S. Global AIDS Ambassador Eric Goosby and the Office of the Global AIDS Coordinator (OGAC) to guide future PEPFAR programs.

19 Nov 2011

Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy

"I know I need this medicine to help lower my chance of cancer recurrence, but it makes my joints ache and stiff. It makes me feel old and I am not sure I can take this medication much longer."

19 Nov 2011

Combo hormone therapy increases risk of breast cancer in women with new-onset tenderness

The debate about using menopausal hormone therapies to relieve symptoms in post-menopausal women has been ongoing. Is the combination therapy of estrogen and progestin better or worse than just giving women estrogen alone? In women who still have a uterus (those who have not had a hysterectomy), progestin counteracts the increased risk of uterus cancer when estrogen is given alone, but at the expense of an increase in breast cancer risk compared to estrogen alone.

19 Nov 2011

HRR1 after 6MW test is a strong predictor of clinical worsening in IPAH patients

Heart rate recovery at one minute after a six-minute walking distance (6MWD) test is highly predictive of clinical worsening and time to clinical worsening in patients with idiopathic pulmonary arterial hypertension (IPAH), according to a new study.

19 Nov 2011

Therapy News and Research

CRF to sponsor Women's Heart Health Summit

Gene-therapy trial to restore hearing in deaf mice

Scientists search for main culprit behind Sj-gren's syndrome

Researchers manipulate life span of yeast by mutating chemical residues

FDA clears TSC's OncoTrac medical imaging software

Scientists design math model that could guide future prostate cancer treatments

Study reveals PEA-15 protein can enhance cancer cell proliferation

Despite market constraints, the drug market for key hospital-treated infections will increase: Report

Covidien to acquire BÂRRX Medical

2011 National Report Card on Lung Cancer notes significant change in grade for early detection

PLoS ONE publishes study on darinaparsin, a multivalent chemotherapeutic

Multi-center cabozantinib trial for hormone receptor-positive breast cancer with bone metastases initiated

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

FDA grants HDE marketing approval for BSD-2000 Hyperthermia System to treat cervical cancer

OTS to market and disribute RaySearch's RayStation in South Korea

Convergence commences CNV2197944 multiple ascending dose Phase I study for chronic pain

PEPFAR Scientific Advisory Board report offers six recommended research priorities

Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy

Combo hormone therapy increases risk of breast cancer in women with new-onset tenderness

HRR1 after 6MW test is a strong predictor of clinical worsening in IPAH patients

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News